Search
Tanuxiciclib
go.drugbank.com/drugs/DB21504ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Tanuxiciclib is a cyclin dependant kinase inhibitor. Tanuxiciclib has a monoisotopic molecular weight of 312.11 Da.
Asnuciclib
go.drugbank.com/drugs/DB21530ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Asnuciclib is a cyclin dependant kinase inhibitor. Asnuciclib has a monoisotopic molecular weight of 394.07 Da.
Neracorvir
go.drugbank.com/drugs/DB21630ExperimentalThe usage of the INN stem '-corvir' in the name indicates that Neracorvir is a core protein (Cp) inhibitor. Neracorvir has a monoisotopic molecular weight of 419.12 Da.
Tacaciclib
go.drugbank.com/drugs/DB21644ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor. Tacaciclib has a monoisotopic molecular weight of 528.28 Da.
Fovinaciclib
go.drugbank.com/drugs/DB21721InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor. Fovinaciclib has a monoisotopic molecular weight of 548.3 Da.
Zeprumetostat
go.drugbank.com/drugs/DB21740InvestigationalThe usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor. Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.
Placental Mesenchymal Stem Cells
go.drugbank.com/drugs/DB15730InvestigationalIt can be obtained relatively easily as medical waste from which MSCs can be non-invasively extracted and without the ethical issues that come with embryonic stem cells.
Methohexital
go.drugbank.com/drugs/DB00474ApprovedAn intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.
KC706
go.drugbank.com/drugs/DB05157InvestigationalKC706 is a novel anti-inflammatory drug that works by inhibiting the activity of p38 MAP kinase.
Naptumomab estafenatox
go.drugbank.com/drugs/DB12807InvestigationalNaptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.